ESPN's Andrew Brandt Final Addition to #C4CT Concussion Awareness Summit

        Print
| Source: Amarantus BioScience Holdings, Inc.

Final logistics set for pioneering conference during Super Bowl week featuring NFL Network's Andrea Kremer and more than 15 professional athletes including Jeremy Shockey, Carl Eller and Clinton Portis alongside Dr. Robert Cantu, Dr. Robert Stern and other elite scientists to discuss concussion awareness, diagnostics and treatments in development

NEW YORK, MINNEAPOLIS and SAN FRANCISCO, Jan. 27, 2014 (GLOBE NEWSWIRE) -- Amarantus BioScience Holdings, Inc. (OTCQB:AMBS), a biotechnology company developing new treatments and diagnostics for diseases associated with the endoplasmic reticulum stress, cell cycle dysregulation, neurodegeneration and apoptosis, and Brewer Sports International (BSI), a multi-faceted global sports advisory firm, today announced the addition of ESPN's Andrew Brandt as a moderator for the Amarantus BioScience #C4CT Summit hosted by Brewer Sports International, powered by MDM Worldwide. Mr. Brandt will be moderating a panel with Leigh Steinberg, CEO of Steinberg Sports, NFL Concussion Litigation Co-Lead Counsel Christopher Seeger and Chairman of the NFL Retired Players Association Carl Eller, in addition to a panel with former NFL greats Clinton Portis, Jeremy Shockey, Antonio Pierce and current NFL players Green Bay Packer Jermichael Finley and Seattle Seahawk Sidney Rice. In addition, Amarantus President & CEO Gerald Commissiong will be making a presentation during the diagnostics panel on use of the LymPro Test ® in TBI/CTE.

WHAT: Hosted by Brewer Sports International (BSI) and Amarantus BioScience Holdings, Inc. (AMBS), powered by MDM Worldwide, the 2nd Annual #C4CT Concussion Awareness Summit during the 4th Annual Brewer Sports Symposium will be held on January 29, 2014 in New York City, NY as a part of BSI's week long Super Bowl Event Series. To view the final agenda and confirmed panelists, click here.

WHERE: United Nations Headquarters, entrance at 43rd St and 1st Avenue. Summit in Trusteeship Council Room.

WHEN: Wednesday, January 29th, 2014. Check-In begins at 7:00am. Event runs until 6:30pm with reception to follow. Government issued photo identification is required for entry into the United Nations via the 43rd St. security entrance.

WHO: The #C4CT Concussion Awareness Summit will feature speakers such as CEO of Steinberg Sports Leigh Steinberg, Dr. Robert Cantu, Dr. Robert Stern Ph.D., Julian Bailes, M.D., Chris Nowinski, NFL Network's Andrea Kremer, current and former NFL Players Clinton Portis, Carl Eller, Robert Griffith, Antonio Pierce, Jeremy Shockey, Jermichael Finley and many more. Special thanks to all of the generous sponsors including XLNTbrain, Dominion Capital Investments, Aegis Capital Corp., Sichenzia Ross Friedman and Ferrence, LLP and H.C. Wainwright & Co., LLC that have contributed to making the #C4CT Summit happen.

WEBCAST: The #C4CT Summit will be broadcast live from the official UN Television Network. Direct links will be made available on Tuesday evening via Twitter and at www.c4ctsummit.com

LIMITED SEATING STILL AVAILABLE: All-Access VIP summit registration is officially closed. Limited conference seating still available for approved members of the academia community, NGOs and Biotech companies available at no cost. This offer excludes access to all meals, the lunch keynote session and the private reception. Please visit www.c4ctsummit.com for further information and RSVP instructions. RSVP is mandatory by Tuesday, January 28th at 12:00pm EST. RSVP's will be accepted on a first-come, first-served basis and pending approval.

SPONSORSHIP OPPORTUNITIES STILL AVAILABLE: There are still limited sponsorship opportunities available. Please e-mail danielle.berman@thebrewergroup.com for further details.

DONATIONS: #C4CT is raising funds towards ONE MIND for Research™ in a continued effort to support TBI research and innovative treatment solutions. If you'd like to donate, or for more information, please visit www.1mind4research.org.  

WHY: The Brewer Sports Symposium unites business leaders, high-level executives, renowned scientists, international diplomats, major media outlets, educators and current and former professional athletes to address, examine and analyze some of the most pressing topics affecting sports worldwide including; business of sport, media and the law, concussions in sport, athlete career transitions and sport for development in effort to create an open dialogue by using sport as a tool to educate and foster social change.

About Amarantus

Amarantus is a biotechnology company developing treatments and diagnostics for diseases associated with neurodegeneration and protein misfoling-related apoptosis. The Company has licensed Eltoprazine a phase 2b ready Parkinson's Levodopa induced dyskinesia. The Company has an exclusive worldwide license to the Lymphocyte Proliferation test ("LymPro Test®") for Alzheimer's disease and owns the intellectual property rights to a therapeutic protein known as Mesencephalic-Astrocyte-derived Neurotrophic Factor ("MANF") and is developing MANF-based products as treatments for brain disorders. Amarantus is a Founding Member of the Coalition for Concussion Treatment (#C4CT), a movement initiated in collaboration with Brewer Sports International seeking to raise awareness of new treatments in development for concussions and nervous-system disorders. The Company also owns intellectual property for the diagnosis of Parkinson's disease ("NuroPro") and the discovery of neurotrophic factors ("PhenoGuard"). For further information please visit www.Amarantus.com, or connect with the Company on Facebook, LinkedIn, Twitter and Google+.

About Brewer Sports International

Brewer Sports International (BSI) is a multi-faceted global sports advisory firm within The Brewer Group Companies with a focus on the business of sports, wellness and media for professional athletes, sports agencies, public and private corporations and various partners including international organizations, governments and NGOs. Based in Minneapolis, with offices in New York, Dallas, Miami, Beijing and Malawi, BSI was founded by Jack Brewer, a five-year National Football League (NFL) veteran and former team captain on three NFL teams. Additionally, BSI has created a unique financial services platform that is offered to professional athletes and sports agencies, as well as high net worth individuals and businesses touching professional sports. BSI takes pride in enabling its clients to capitalize on the endless opportunities presented through sport. For more information, please visit www.brewersports.com.

Twitter: www.twitter.com/brewersports, Facebook: www.facebook.com/BrewerSportsInternational, LinkedIn: www.linkedin.com/company/brewer-sports-international

About MDM Worldwide

MDM Worldwide Solutions, Inc. is a digital communications agency that develops and manages online engagement strategies to connect companies with their stakeholders. MDM specializes in working with clients in the technology, healthcare and life sciences spaces. Our vast industry knowledge, proprietary methodology, proven track record and experienced leadership team enables us to create and customize targeted digital marketing campaigns to fulfill all of our clients' objectives.

Certain statements, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are forward-looking statements." These forward-looking statements generally are identified by the words believes," project," expects," anticipates," estimates," intends," strategy," plan," may," will," would," will be," will continue," will likely result," and similar expressions. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties which may cause actual results to differ materially from the forward-looking statements. Our ability to predict results or the actual effect of future plans or strategies is inherently uncertain. Factors which could have a material adverse effect on our operations and future prospects on a consolidated basis include, but are not limited to: changes in economic conditions, legislative/regulatory changes, availability of capital, interest rates, competition, and generally accepted accounting principles. These risks and uncertainties should also be considered in evaluating forward-looking statements and undue reliance should not be placed on such statements.

Brewer Sports International:
Danielle Berman, Director of Business Development & Media

443.841.4667

Amarantus Bioscience Holdings, Inc.:
Aimee Boutcher, Director of Investor Relations
408.737.2734 x 101